what is an announcement bar

Increased sugar intake is a major contributing factor to rising obesity levels which research shows increase the risk of developing gut cancers including; oesophageal, stomach, liver and pancreatic cancer.The main cause of weight gain comes down to sugar intake, in fact, it ...
Read more
One of the options for GIVE IT UP for Gut Cancers is to go booze-free. After Christmas and New Years, many of us are thinking about our alcohol consumption and this has been a popular choice for GIU 2025! Here's some food for thought:❌ Limiting alcohol consumption can help...
Read more
Today Pharmac has confirmed that Lenvatinib (Lenvima) will be available from 1 December for eligible patients with advanced unresectable Hepatocellular Carcinoma.This is a very welcome but long-awaited step forward and the first-time liver cancer patients in Aotearoa will be...
Read more
1 November Update: Cetuximab (Erbitux) is now funded for some bowel  cancer patients. To find out more, check eligibility and download resources including questions to ask your medical team, visit the Erbitux website.GCF is delighted to see today’s announcement that C...
Read more
The Gut Cancer Foundation (GCF) has today provided feedback to Pharmac as part of their consultation process for funding the liver cancer treatment, lenvatinib (Lenvima). Lenvatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an ...
Read more
The Gut Cancer Foundation is heartened to receive news of widened access of pembrolizumab (Keytruda) for microsatellite instability high or deficient mismatch repair (MSI-H/dMMR) colorectal cancer (CRC) patients.  Pharmac has listened to clinici...
Read more
Earlier this month, Pharmac called for feeback on their proposal to widen access to Pembrolizumab to treat microsatellite instability-high or deficient mismatch repair (MSI-H/dMMR) colorectal cancer.We and the community we represent welcome the proposal. For a patient g...
Read more
The Gut Cancer Foundation has today written to Pharmac in response to news released on Friday August 9th that they have issued a Future Procurement Opportunity (FPO) for the cancer treatment bevacizumab.Aotearoa/New Zealand remains an outlier with no funded systemic options ...
Read more
The Gut Cancer Foundation is delighted by Pharmac’s announcement today that they are proposing to fund Pembrolizumab (Keytruda) for patients with microsatellite instability-high or deficient mismatch repair (MSI-H/dMMR) colorect...
Read more
Yesterday's announcement of $604 million investment over four years to fund up to 26 cancer treatments is fantastic news for New Zealanders living with cancer. We are very pleased to see that the announcement includes the fulfilment of a promise to fund 2 new cancer drugs fo...
Read more
Load more
Loading...
Load more
Loading...